Breaking News
Get 40% Off 0
🔎 See NVDA full ProTips for an instant risks or rewards Claim 40% OFF
Close

Pfizer Inc (PFE)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Pfizer's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
26.89 -0.29    -1.07%
05:00:00 - Closed. Currency in USD ( Disclaimer )
After Hours
26.93
+0.04
+0.15%
8:59:56 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 33,532,929
  • Bid/Ask: 26.91 / 26.93
  • Day's Range: 26.81 - 27.19
Pfizer 26.89 -0.29 -1.07%

PFE Recent Sentiments

 
This page features our users' sentiments regarding the Pfizer Inc stock. They are displayed on both charts of different time periods and in a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Feb 29, 2024 eric chau   26.93 -0.15%
Feb 27, 2024 Yusuke Tanaka   26.98 -0.33%
Feb 27, 2024 יניב אטיאס   27.00 -0.41%
Feb 27, 2024 Nikola Milenkovic   26.98 -0.33%
Feb 27, 2024 djali mille   26.99 -0.37%
Feb 27, 2024 Igor Doubovski   26.99 -0.37%
Feb 27, 2024 Serhat Özakyol   26.99 -0.37%
Feb 27, 2024 Felix Salan De Castro   26.96 +0.26%
Feb 27, 2024 theerapong nitpirom   26.95 Feb 27, 2024 @ 26.94 -0.04%
Feb 27, 2024 spoo ok   26.97 +0.30%
Feb 27, 2024 Geunsoo Song   26.82 +0.26%
Feb 27, 2024 Pier R   26.84 -0.19%
Feb 27, 2024 Roy Porat   26.92 -0.11%
Feb 27, 2024 Damian Angeletti   27.00 -0.41%
Feb 27, 2024 Silvia Pegoraro   27.00 -0.41%
Feb 27, 2024 Marcelo Alves   27.17 +1.03%
Feb 26, 2024 Alfonso Ravecca   27.21 -1.18%
Feb 26, 2024 Jason Spatafora   27.18 -1.07%
Feb 26, 2024   27.16 -0.99%
Feb 26, 2024 Marco Nardi   27.12 -0.85%
Feb 26, 2024 Paweł Andrzejewski   27.10 -0.77%
Feb 26, 2024 Aa Ro   27.18 -1.07%
Feb 26, 2024 Emmanuel Gilloteaux   27.19 +1.10%
Feb 26, 2024 Максим Чуприянов   27.16 -0.99%
Feb 26, 2024 Assylbek Kossamanov   27.18 -1.07%
Feb 26, 2024 Anton Jermakov   27.16 -0.99%
Feb 26, 2024 Juhani Vesterinen   27.17 -1.03%
Feb 26, 2024 Pererik Grönberg   27.19 Feb 26, 2024 @ 27.21 -0.07%
Feb 26, 2024 Jose Antonio Cortes   27.41 +1.90%
Feb 26, 2024 Adrian Navajas   27.00 -0.41%
Feb 26, 2024 Максим Чуприянов   27.79 Feb 26, 2024 @ 27.21 -2.09%
Feb 26, 2024 MutantSoft Gera   27.79 Feb 26, 2024 @ 27.21 +2.09%
Feb 26, 2024 oscar leal   27.00 Feb 26, 2024 @ 27.21 +0.78%
Feb 23, 2024 Franco Vasconetto   27.80 Feb 26, 2024 @ 27.21 -2.12%
Feb 23, 2024 Rodrigo Santibanez   27.82 -3.34%
Feb 23, 2024 Amen Arley   27.83 Feb 26, 2024 @ 27.20 -2.26%
Feb 23, 2024 Daniele Cinà   27.98 -3.90%
Feb 23, 2024 Marcia Scavino   28.00 Feb 26, 2024 @ 27.21 -2.82%
Feb 23, 2024 Aaron Kaatz   27.83 +3.38%
Feb 23, 2024 Lâm Đoàn   27.67 Feb 26, 2024 @ 27.21 -1.66%
Feb 22, 2024 Agustin Ravazzini   27.55 -2.40%
Feb 22, 2024 ygal hausman   27.55 -2.40%
Feb 22, 2024 Robert S   27.61 -2.61%
Feb 22, 2024 William Deng   27.39 Feb 26, 2024 @ 27.21 -0.66%
Feb 22, 2024 Ugur Balci   27.34 +1.65%
Feb 22, 2024 Hamza Talha   27.27 -1.39%
Feb 22, 2024 도훈 김   27.64 Feb 26, 2024 @ 27.21 -1.56%
Feb 22, 2024 Danilo Di Salvo   27.64 Feb 26, 2024 @ 27.21 -1.56%
Feb 22, 2024 Marcelo Souza   27.58 Feb 26, 2024 @ 27.21 -1.34%
Feb 21, 2024 Kemal Coban   27.48 -2.15%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PFE Comments

Write your thoughts about Pfizer Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email